Anti-CD20 multivalent HPMA copolymer-Fab' conjugates for the direct induction of apoptosis
about
Polymer-drug conjugates: origins, progress to date and future directionsImmunogenicity of coiled-coil based drug-free macromolecular therapeutics.Macromolecular therapeuticsDrug-free macromolecular therapeutics induce apoptosis of patient chronic lymphocytic leukemia cellsMultimodality imaging of coiled-coil mediated self-assembly in a "drug-free" therapeutic system.A Two-Step Pretargeted Nanotherapy for CD20 Crosslinking May Achieve Superior Anti-Lymphoma Efficacy to RituximabDrug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric NanomedicinesConstruction and characterization of an anti-CD20 mAb nanocomb with exceptionally excellent lymphoma-suppressing activity.Synthesis of long-circulating, backbone degradable HPMA copolymer-doxorubicin conjugates and evaluation of molecular-weight-dependent antitumor efficacySynergistic anti-tumor therapy by a comb-like multifunctional antibody nanoarray with exceptionally potent activity.Polymeric drugs: Advances in the development of pharmacologically active polymers.POLYMERIC BIOMATERIALS AND NANOMEDICINES.Cellular uptake and cytotoxicity of drug-peptide conjugates regulated by conjugation siteTargeted drug delivery and cross-linking induced apoptosis with anti-CD37 based dual-ligand immunoliposomes in B chronic lymphocytic leukemia cells.Tracking and quantifying polymer therapeutic distribution on a cellular level using 3D dSTORMCell surface self-assembly of hybrid nanoconjugates via oligonucleotide hybridization induces apoptosis.CD20-targeting in B-cell malignancies: novel prospects for antibodies and combination therapies.Covalent nano delivery systems for selective imaging and treatment of brain tumors.Design of smart HPMA copolymer-based nanomedicines.DNA-scaffolded multivalent ligands to modulate cell function.Drug-free macromolecular therapeutics: Impact of structure on induction of apoptosis in Raji B cells.
P2860
Q27002505-E6294397-5B44-4515-89DC-EA557A7D4227Q33602669-25B2255F-38CE-424C-B718-B3877881FFEEQ34079574-D5DBF502-A925-44FD-A6C3-386DE9FCFAB5Q34855819-A466DF7F-19F2-4947-8EDB-07E0922B7180Q35611416-FDF3A322-5FA2-403F-8965-B94DD2A372F5Q35633346-347FB80E-F2D8-4340-8ABB-E249DF908234Q35861726-5230B936-8F17-4992-95AF-751756FEC4D6Q35918821-9C9ABD8D-E5B0-48B3-AD15-F94C813B0CFCQ36126612-FF7A5FBF-6363-41D3-883E-A2726ECEE99BQ36217155-6AD32EB7-030F-4265-93FA-F7AB4241E79DQ36307604-05DD57D2-9C38-405C-AE1B-E23311B3F986Q36376467-D96A7472-CA26-43B2-AB02-1F861676854BQ36837220-C9382A7C-3DF9-4FAE-80CD-2142C736E929Q37129235-B6D02ED6-FE3B-4D82-9226-3DEA30E77845Q37341499-69CD1514-C6C8-4698-A23F-3B98A5066E64Q37537969-B36D709F-1BFE-420D-A777-550CC4B1F576Q38807514-23C9D459-6940-44E7-BF7B-E17225BAD796Q39367664-82EAB0F0-1634-42E5-9866-3D1F1C0CA74BQ42553783-38482822-0D7E-451A-884D-5E2F45BA0332Q46196202-E8644411-3C42-4CBB-9946-7C5F1B9FBBDAQ53609318-B5CE2F6F-6A8A-4E8F-8E4A-60E5F08B045B
P2860
Anti-CD20 multivalent HPMA copolymer-Fab' conjugates for the direct induction of apoptosis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Anti-CD20 multivalent HPMA cop ...... direct induction of apoptosis
@ast
Anti-CD20 multivalent HPMA cop ...... direct induction of apoptosis
@en
type
label
Anti-CD20 multivalent HPMA cop ...... direct induction of apoptosis
@ast
Anti-CD20 multivalent HPMA cop ...... direct induction of apoptosis
@en
prefLabel
Anti-CD20 multivalent HPMA cop ...... direct induction of apoptosis
@ast
Anti-CD20 multivalent HPMA cop ...... direct induction of apoptosis
@en
P2093
P2860
P1433
P1476
Anti-CD20 multivalent HPMA cop ...... direct induction of apoptosis
@en
P2093
Jindřich Kopeček
Jiyuan Yang
Te-Wei Chu
P2860
P304
P356
10.1016/J.BIOMATERIALS.2012.06.024
P577
2012-07-12T00:00:00Z